MUMBAI, (REUTERS) – Adar Poonawalla, CEO of vaccine maker Serum Institute of India, will buy a 50% stake in filmmaker Karan Johar’s Dharma Productions for 10 billion rupees ($119 million), the ...
Karan Johar sells a 50% stake in Dharma Productions to Adar Poonawalla’s Serene Productions for ₹1,000 crore, sharing his ...
Welcome to the live updates platform for Hindustan Times. Follow the major news updates, headlines and breaking news stories ...
It was recently announced that billionaire businessman Adar Poonawalla’s Serene Productions will invest ₹10 billion in Karan ...
Adar Poonawalla-led Serene Productions has announced that it has entered into a binding agreement to invest ₹1,000 crore into Karan Johar’s Dharma Productions and Dharmatic Entertainment.
Bollywood filmmaker Karan Johar recently sparked curiosity among fans with a cryptic social media post following his deal with businessman Adar Poonawalla. On Sunday, Karan Johar shared an ...
UNICEF’s Executive Director calls on the international community to step up and support humanitarian response and recovery efforts in Haiti as children and families continue to suffer: “Now is ...
Also Read: Adar Poonawalla’s Rising Sun Holdings buys 1.75-lakh square feet office space in Pune for ₹395 crore The institute also produces 1.5 billion doses of vaccines for polio, the flu and ...
Days after buying Karan Johar's firm, Adar Poonawalla gets ready to sell 40% stake in one of his companies for Rs.... Billionaire Adar Poonawalla-led Serum Institute is all set for a major deal.
Karan Johar’s Dharma Productions has been making headlines recently. News broke that Adar Poonawalla, CEO of Serum Institute of India, through his Serene Productions, acquired a 50% stake in ...
Shares of Poonawalla Fincorp, the Cyrus Poonawalla Group-promoted non-banking financial company (NBFC), crashed on Friday after the firm posted a net loss in the September quarter of the financial ...
Billionaire Adar Poonawalla-led Serum Institute of India has held discussions with global private equity firm TPG to sell 40% stake held by the top vaccine maker in SCHOTT Poonawalla, four people ...